Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
167%(5 trials)
Terminated
2(40%)

Phase Distribution

Ph phase_3
2
40%
Ph phase_2
3
60%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (60.0%)
Phase 32 (40.0%)

Trials by Status

terminated240%
completed360%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_3

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

NCT02357459
completedphase_2

Study of FX006 in Patients With Osteoarthritis of the Knee

NCT01487161
terminatedphase_3

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

NCT03793010
terminatedphase_2

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

NCT04160091
completedphase_2

Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis

NCT04182672

Clinical Trials (5)

Showing 5 of 5 trials
NCT02357459Phase 3

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Completed
NCT01487161Phase 2

Study of FX006 in Patients With Osteoarthritis of the Knee

Completed
NCT03793010Phase 3

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Terminated
NCT04160091Phase 2

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Terminated
NCT04182672Phase 2

Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5